Date and time
Start: Thursday 23 March 2023, 12:30 PM
End: Thursday 23 March 2023, 07:00 PM
Thursday 23 March
Start: Thursday 23 March 2023, 12:30 PM
End: Thursday 23 March 2023, 07:00 PM
Clayton Hotel Cambridge, 27-29 Station Rd,, Cambridge, CB1 2FB
The East of England Meeting will be taking place on the 23 March 2023 at Clayton Hotel Cambridge.
Don’t miss out on an opportunity to listen to key talks by our speakers and network with members in the Cambridgeshire area!
The safety of our members here at CIPA is paramount therefore we have created a COVID-19 Policy for in person events. At all in person events the venues we have carefully chosen will have increased cleaning including sanitizing stations, along with increased ventilation. Lastly, we advise any delegates who are feeling unwell not to attend an in person event. Thank you for your cooperation and on going support.
Howard worked extensively both in industry on new products and in the academic sector before retraining as a patent attorney in 2014. Howard not only appreciates the business value derivable from intellectual property but also the business cost due to the intellectual property of others.
Howard is particularly keen on developments in legislation and case law and regularly represents before the Opposition Divisions and Boards of Appeal.
As well as a BA (Hons) and MA in Natural Sciences, Howard also has a PhD in metallurgy. In addition, Howard has a BSc (Hons) in Technology, a MSc in Computing and a LLM in Intellectual Property Law.
Howard is a Partner at Appleyard Lees and has recently relocated from Manchester back to Cambridge. A member of the CIPA International Liaison Committee and of FICPI-UK Council, Howard promotes UK patent attorneys globally.
Richard has over 20 years’ experience litigating before the English Patent Court as well as oppositions and appeals before the EPO and is equally familiar with both jurisdictions.
Before commencing practice at the Bar, Richard qualified as a European Patent Attorney and this dual qualification has resulted in him appearing frequently before the European Patent Office and giving him representation rights before the UPC.
Richard’s practice encompasses a diverse range of technologies. He has particular expertise in the electronics / telecommunications sector having advised many of the major players in the field such as LG Electronics, Samsung, Nokia, Motorola and Symbian. Although by training an electrical engineer, he is active in the pharmaceutical sector and acted for the Secretary of State for Health in the ground breaking second medical indication litigation concerning pregabalin.
Richard lectures and tutors regularly on IPRs to patent and trade mark attorneys and solicitors. He has tutored at Nottingham Law School on its LLM in Advanced IP litigation and been a visiting lecturer of CEIPI on the European patent litigation diploma. Richard is now one of the two General Editors of the CIPA Guide to the Patents Acts (the Black Book).
It was recently announced that he will be appointed King’s Counsel (silk) in early 2023.
With over thirty years’ experience working in private practice and in-house for a large pharmaceutical firm, Nicola has dealt with all aspects of intellectual property. Nicola joined Appleyard Lees in 2017. As Head of IP Business Services, Nicola works with the partners and operational managers to develop a strategy for business services that meets the needs of the firm now, and in future. Nicola is responsible for paralegal support and works closely with the business to implement best practices and processes that benefit our clients. She develops and delivers in-house training, and ensures all internal processes are updated and documented. Most recently, Nicola has been involved in the development and implementation of the firm’s UP/UPC-related processes and has designed and delivered relevant training to technical and support staff.
Lee-Ann joined the intellectual property profession in 2007 working various support roles in private practice. She is currently the Head of Data and Systems for Appleyard Lees IP LLP specialising in the design, implementation and maintenance of IP systems. She is also a fully qualified CITMA and CIPA Paralegal.
Mark has over 20 years’ experience as a patent attorney, working both in-house and in private practice. Mark is currently a member of the IP leadership team at AstraZeneca where he is accountable for the delivery of IP strategy across the oncology pharmaceuticals function and for the implementation of SPC/PTE strategy across the business. In addition to these responsibilities, he has been leading AZ’s UP/UPC preparedness team.
Rob is a Patent Attorney at AstraZeneca where he supports a number of projects and platform technologies relating to pharmaceuticals, antibody drug conjugates and oligonucleotides. Prior to joining the patent profession in 2017, Rob worked as a postdoctoral researcher for AstraZeneca. Rob has a PhD in organic chemistry from University College London and an MChem from Oxford University. Rob is a member of AstraZeneca’s UPC team, dealing with matters relating to opt-outs, unitary patents and the registration of EPAs as Representatives before the UPC.
Eve-Marie Mayer-Martin is Director at the European Patent Office and is currently responsible for the patent grant process in the area of Medical Electronics and Medical Informatics. After having graduated in Physics at the Technical University of Munich in 1997 she became a European Patent Attorney and worked for several years in the Patent Department of Siemens, where she prepared and prosecuted patent applications and advised several Business Units in all patent law issues. She joined the EPO in 2001 as a patent examiner and was appointed director in 2013. Since 2004 she has been an active member of the Examination Committee responsible for the legal paper of the European Qualifying Examination for patent attorneys.
Sarah is an IP Attorney at Pragmatic Semiconductor, who are revolutionising semiconductor fabrication with ultra-low-cost, flexible integrated circuit (FlexIC) technology that makes it quick and easy to embed intelligence almost anywhere. Sarah’s role involves the management of Pragmatic’s patent portfolio, developing in-house processes and systems for IP capture, as well as advising on IP strategy and collaboration agreements. Sarah has also worked in private practice and has gained a wealth of experience in areas such as patent prosecution across a number of jurisdictions, EPO oppositions, FTO opinions, and patent filing strategies. During her time in private practice, Sarah also gained experience of working in the in-house IP department of a multinational petrochemical company as part of a 5-month extended assignment. Sarah holds an MChem and PhD in Chemistry, as well as an MRes in Sustainable Chemical Technologies from the University of Bath. Prior to joining the patent profession, Sarah was a research project coordinator at the Green Chemistry Centre of Excellence (GCCE) at the University of York. During her time at the GCCE, Sarah worked on a pan European project aimed at the development of sustainable manufacturing methods for the 21st century pharmaceutical industry (CHEM21), and managed a number of projects marked for spin-out.
Amy is a European and UK patent attorney with a broad range of experience in IP matters, having worked both in-house and in private practice. After graduating with a degree in Astrophysics from University College London, Amy spent a number of years at a leading IP firm in London, gaining significant experience in patent drafting and prosecution as well as in oppositions before the EPO.
More recently, as a Senior Patent Attorney at Cambridge Mechatronics Amy provides commercially-focused advice on a number of issues, from questions around freedom-to-operate and commercial agreements to patent filing strategy, as well as continuing to enjoy drafting and prosecution.
Technology-wise, Amy has worked in a number of areas, including algorithms and computer-implemented inventions, but has particular experience and affinity with mechanical inventions, especially actuators, which is her current focus.
Charlotte Jones is Intellectual Property Counsel at Viatris, a global healthcare company formed in 2020 through the combination of Mylan and Pfizer’s Upjohn business. In her role, she focuses on conducting freedom-to-operate analysis, EPO oppositions and appeals, prosecution, and advising on intellectual property strategy including litigation. She has a particular interest in data exclusivity and supplementary protection certificate case law.
Charlotte holds an MChem and PhD from the University of St Andrews, with her PhD research focussed on homogeneous asymmetric catalysis. She obtained an LLM in Intellectual Property Law from the University of Manchester with a research project evaluating the validity of combination supplementary protection certificates. Charlotte is a committee member for both the Royal Society of Chemistry Law Group and Careers in Ideas.
Kathryn is a part-qualified patent attorney in the in-house IP team at Ocado, mostly working on drafting and prosecuting patent applications to protect different aspects of technology for automated storage systems. Kathryn holds an MPhys in Physics from the University of Oxford, a PhD in physics from the University of Nottingham, an MSc in Engineering from Open University, and is a Chartered Engineer. After 10 years working in industry as an engineer, Kathryn joined the patent profession in 2019. Kathryn is the Hon Sec of CIPA Informals, heading the committee and representing student members of CIPA.
Faye Holland wears many hats within Cambridge’s famed technology sector, influencing, inspiring and connecting on many different levels, always driving Cambridge’s global reputation as the UK’s centre for Technology, Innovation and Science.
Having spent over 25 years in numerous emerging business opportunities, from the first ISP in the UK, to IBM, to running the European and Asia-Pacific operations of a global media company, Faye brings a broad portfolio of experience to all her work. Her multi-award-winning specialist PR and communications consultancy, cofinitive, is focused on promoting innovative and disruptive early-stage startups through to scaleups and large corporates with a focus on tech and innovation.
Beyond Cambridge, Faye is widely known as the creator and organiser of the influential #21toWatch Technology Innovation Awards, and is a committed and passionate mentor for future technology entrepreneurs.
After seven years working in hospital medicine, Robert worked in development and regulatory roles at Sanofi, the MHRA and Roche. Robert then spent a decade at early stage biotech companies including Arakis (sold to Sosei Inc), founder and CEO at Treague, founding CEO of the University of Copenhagen spin -out Avilex Pharma and part of the founding management team of KalVista (Nasdaq: KALV). Robert qualified in medicine from UCL. He is a member of the Royal College of Obstetricians & Gynaecologists and the Faculty of Pharmaceutical Medicine and has an MBA from London Business School and an M.Phil in Biostatistics from the University of Cambridge. Robert manages CIC’s investments in Carrick Therapeutics, CMR Surgical, Exvastat, Gyroscope, Inivata, Microbiotica, Morphogen-IX, PetMedix, Pretzel Therapeutics and T-Therapeutics.
The event has been added to your basket:
Sign in to your account to register for the event
If you are not yet registered or a member of CIPA, please register here